Literature DB >> 1772291

Absence of autoimmunity to type II collagen in generalised nodal osteoarthritis.

R B Clague1, K Morgan, I Collins, M Pattrick, M Doherty.   

Abstract

A cardinal feature of generalised nodal osteoarthritis is the loss of articular cartilage. To determine if autoimmunity to these cartilage collagens occurred, serum antibodies to native and denatured type II collagen were measured by enzyme linked immunosorbent assay (ELISA) in 96 patients (90 women, six men, aged 47-91 years) with generalised nodal osteoarthritis. Generalised nodal osteoarthritis was diagnosed by typical clinical and radiological features. Serum samples from 42 blood donors were assayed as controls. No significant difference was found between the patients with generalised nodal osteoarthritis and the controls. Furthermore, the 20 patients who were HLA-A1, B8 positive had similar antibody levels to the group as a whole. One woman patient with generalised nodal osteoarthritis (HLA-A1, B8 negative) had markedly increased antibody levels to native and denatured type II collagen in a pattern similar to that seen in patients with rheumatoid arthritis. This patient did not develop super added rheumatoid arthritis during a three year follow up period. Autoimmunity to type II collagen is therefore rare in generalised nodal osteoarthritis. A lack of collagen antibodies in a condition characterised by hyaline cartilage loss suggests that the presence of such antibodies in rheumatoid arthritis is more than a secondary event to joint damage.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1772291      PMCID: PMC1004555          DOI: 10.1136/ard.50.11.769

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  8 in total

Review 1.  What do anti-collagen antibodies mean?

Authors:  K Morgan
Journal:  Ann Rheum Dis       Date:  1990-01       Impact factor: 19.103

2.  HLA-A, B antigens and alpha 1-antitrypsin phenotypes in nodal generalised osteoarthritis and erosive osteoarthritis.

Authors:  M Pattrick; A Manhire; A M Ward; M Doherty
Journal:  Ann Rheum Dis       Date:  1989-06       Impact factor: 19.103

3.  The synovial membrane in osteoarthritis: a histological study including the characterisation of the cellular infiltrate present in inflammatory osteoarthritis using monoclonal antibodies.

Authors:  P A Revell; V Mayston; P Lalor; P Mapp
Journal:  Ann Rheum Dis       Date:  1988-04       Impact factor: 19.103

4.  Autoimmunity to native type II collagen--a distinct genetic subset of rheumatoid arthritis.

Authors:  P S Klimiuk; R B Clague; D M Grennan; P A Dyer; I Smeaton; R Harris
Journal:  J Rheumatol       Date:  1985-10       Impact factor: 4.666

5.  The deposition of immunoglobulins and complement in osteoarthritic cartilage.

Authors:  T D Cooke; E L Bennett; O Ohno
Journal:  Int Orthop       Date:  1980       Impact factor: 3.075

6.  Incidence of antibodies to native and denatured cartilage collagens (types II, IX, and XI) and to type I collagen in rheumatoid arthritis.

Authors:  K Morgan; R B Clague; I Collins; S Ayad; S D Phinn; P J Holt
Journal:  Ann Rheum Dis       Date:  1987-12       Impact factor: 19.103

7.  Generalized osteoarthritis and Heberden's nodes.

Authors:  J H KELLGREN; R MOORE
Journal:  Br Med J       Date:  1952-01-26

8.  Anomalous reactions in the haemagglutination assay for anti-collagen antibodies: studies on patients with rheumatoid arthritis or chronic low back pain.

Authors:  H K Beard; D J Lea; R Ryvar
Journal:  J Immunol Methods       Date:  1979       Impact factor: 2.303

  8 in total
  1 in total

1.  Absence of immunity to type II collagen and proteoglycan in osteoarthritic C57BL mice.

Authors:  K Takagishi; K Maeda; Y Goso; M Itoman; M Yamamoto
Journal:  Inflamm Res       Date:  1995-05       Impact factor: 4.575

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.